Director/PDMR Shareholding

By

Regulatory News | 16 Dec, 2024

RNS Number : 2143Q
Victrex PLC
16 December 2024
 

Director/PDMR Shareholding 

Victrex plc is an innovative world leader in high performance polymer solutions, delivering sustainable products which enable environmental and societal benefit in multiple end-markets.  The company announces that Ian Melling, Chief Financial Officer of Victrex, purchased 2,000 ordinary shares in the Company on 13 December 2024 at a price of £11.365 per ordinary share.

The FCA notification in respect of the above made in accordance with the requirements of the UK Market Abuse Regulation, is appended below.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Ian Melling

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Victrex plc

b)

 

LEI

 

 

213800UYNPHAUNHPXL67

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 1p each-



Identification code

GB0009292243



b)

 

Nature of the transaction

 

 

Purchase of Shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




£ 11.350

2,000







d)

 

Aggregated information

n/a single transaction



- Aggregated volume




- Price




e)

 

Date of the transaction

 

2024-12-13

f)

 

Place of the transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZMMZRVZGDZG

Last news